Credit Suisse Ag Morphic Holding, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 32,223 shares of MORF stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,223

Previous 23,960 34.49%

Holding current value

$1.84 Million

Previous $691,000 64.11%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$26.64 - $40.31 $220,126 - $333,081	8,263 Added 34.49%	32,223 $1.13 Million
Q4 2023 Feb 08, 2024	SELL	$19.95 - $31.0 $26,932 - $41,850	-1,350 Reduced 5.33%	23,960 $691,000
Q3 2023 Nov 13, 2023	SELL	$21.33 - $59.42 $140,372 - $391,043	-6,581 Reduced 20.64%	25,310 $579,000
Q2 2023 Aug 11, 2023	BUY	$34.33 - $62.11 $418,860 - $757,804	12,201 Added 61.97%	31,891 $1.83 Million
Q1 2023 May 10, 2023	BUY	$26.01 - $48.69 $34,073 - $63,783	1,310 Added 7.13%	19,690 $741,000
Q4 2022 Feb 13, 2023	BUY	$24.14 - $30.37 $118,623 - $149,238	4,914 Added 36.49%	18,380 $491,000
Q3 2022 Nov 10, 2022	BUY	$22.23 - $33.37 $15,005 - $22,524	675 Added 5.28%	13,466 $381,000
Q2 2022 Aug 12, 2022	SELL	$19.74 - $43.01 $5,408 - $11,784	-274 Reduced 2.1%	12,791 $277,000
Q1 2022 May 16, 2022	BUY	$36.25 - $52.02 $35,488 - $50,927	979 Added 8.1%	13,065 $524,000
Q4 2021 Feb 14, 2022	BUY	$43.27 - $65.72 $5,927 - $9,003	137 Added 1.15%	12,086 $572,000
Q3 2021 Nov 12, 2021	BUY	$53.61 - $67.5 $52,001 - $65,475	970 Added 8.84%	11,949 $677,000
Q2 2021 Aug 16, 2021	BUY	$45.13 - $64.99 $24,099 - $34,704	534 Added 5.11%	10,979 $630,000
Q1 2021 May 14, 2021	SELL	$29.77 - $84.85 $77,134 - $219,846	-2,591 Reduced 19.88%	10,445 $662,000
Q4 2020 Feb 12, 2021	BUY	$25.66 - $34.55 $334,503 - $450,393	13,036 New	13,036 $437,000

Others Institutions Holding MORF

# of Institutions

Shares Held

4.96M

Call Options Held

Put Options Held

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account